In 2023, the seven major markets (7MM) for trigeminal neuralgia reached a value of $234.5 million. According to IMARC Group, these markets are expected to grow steadily, reaching $357.8 million by 2034, with a compound annual growth rate (CAGR) of 3.92% from 2024 to 2034. This growth is driven by advancements in treatment options and increasing awareness of trigeminal neuralgia, a chr... https://www.imarcgroup.com/trigeminal-neuralgia-market